ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

January 21, 2005

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

IOM Report Links Agent Orange, CLL

January 24, 2003

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976